Meeting
2023 ASCO Annual Meeting
The impact of population pharmacogenomics and risk allele frequencies on cisplatin-induced peripheral sensory neuropathy (PSN).
Authors
Swetha Nakshatri
University of Chicago, Chicago, IL
Swetha Nakshatri , Paul C. Dinh Jr., Darren R. Feldman , Robert James Hamilton , David J. Vaughn , Chunkit Fung , Christian K. Kollmannsberger , Robert A Huddart , Neil E. Martin , Lawrence H. Einhorn , Nancy Cox , Lois B. Travis , M. Eileen Dolan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Symptoms and Survivorship
Track
Symptom Science and Palliative Care
Sub Track
Late and Long-Term Adverse Effects
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 12092)
DOI
10.1200/JCO.2023.41.16_suppl.12092
Abstract #
12092
Poster Bd #
460
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Identification of genetic markers associated with ibrutinib-related cardiovascular toxicity.
First Author: Issam Hamadeh
Poster
2020 ASCO Virtual Scientific Program
Association of polymorphisms in androgen production, uptake, and conversion chain (APUC) genes with mortality of prostate cancer patients.
First Author: Sean Thomas McSweeney
Poster
2017 ASCO Annual Meeting
Comprehensive study of risk factors for chemotherapy-induced nausea and vomiting in cancer patients receiving cisplatin-based chemotherapy: A TRIPLE pharmacogenomics study.
First Author: Hideaki Ayuhara
Poster
2016 ASCO Annual Meeting
Genome wide association study of cisplatin-induced peripheral neuropathy (CIPN) in testicular cancer survivors.
First Author: Omar El Charif